TCT-142 Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement With STS PROM of ≤3%

Jackson King; Morgan Black; Ruyun Jin; Gary Grunkemeier; Brydan Curtis; Robert W. Hodson; Michael Ring

doi:10.1016/J.JACC.2019.08.193

TCT-142 Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement With STS PROM of ≤3%

Jackson King
, Morgan Black
, Ruyun Jin
, Gary Grunkemeier
, Brydan Curtis
, Robert W. Hodson
, Michael Ring

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of the American College of Cardiology
Volume	74
DOIs	https://doi.org/10.1016/J.JACC.2019.08.193
State	Published - Oct 1 2019

Disciplines

Medicine and Health Sciences
Surgery

Access to Document

10.1016/J.JACC.2019.08.193License: Unspecified

Cite this

@article{ffab8f0d0bc946eaa6f1bc5371e39954,

title = "TCT-142 Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement With STS PROM of ≤3\%",

author = "Jackson King and Morgan Black and Ruyun Jin and Gary Grunkemeier and Brydan Curtis and Hodson, \{Robert W.\} and Michael Ring",

note = "Background Transcatheter aortic valve replacement (TAVR) is the preferred treatment for most patients with aortic stenosis deemed at intermediate or higher risk for surgical aortic valve replacement (SAVR). Determination of the risk of SAVR is mainly based on the Society of Thoracic Surgeons (STS) risk calculator.",

year = "2019",

month = oct,

day = "1",

doi = "10.1016/J.JACC.2019.08.193",

language = "American English",

volume = "74",

journal = "Journal of the American College of Cardiology",

}

TY - JOUR

T1 - TCT-142 Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement With STS PROM of ≤3%

AU - King, Jackson

AU - Black, Morgan

AU - Jin, Ruyun

AU - Grunkemeier, Gary

AU - Curtis, Brydan

AU - Hodson, Robert W.

AU - Ring, Michael

N1 - Background Transcatheter aortic valve replacement (TAVR) is the preferred treatment for most patients with aortic stenosis deemed at intermediate or higher risk for surgical aortic valve replacement (SAVR). Determination of the risk of SAVR is mainly based on the Society of Thoracic Surgeons (STS) risk calculator.

PY - 2019/10/1

Y1 - 2019/10/1

UR - https://digitalcommons.psjhealth.org/publications/3467/

U2 - 10.1016/J.JACC.2019.08.193

DO - 10.1016/J.JACC.2019.08.193

M3 - Article

VL - 74

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

ER -

TCT-142 Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Aortic Valve Replacement With STS PROM of ≤3%

Disciplines

Access to Document

Other files and links

Cite this